Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
po odstranitvi transdermalnega obliža
after removing the transdermal patch
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
transdermalnega obliža ne odplaknite v stranišče.
the transdermal patch should not be flushed down the toilet.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
ne nosite transdermalnega obliža v vodi dalj časa.
try to avoid wearing the transdermal patch in water for long periods of time.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
ne hranite transdermalnega obliža zunaj zataljene vrečice.
do not keep or store the transdermal patch outside the sealed sachet.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
lepilo transdermalnega obliža: akrilno-vinilacetatni kopolimer
transdermal patch adhesive: acrylate-vinylacetate copolymer
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
po tem z uporabo transdermalnega obliža evra nadaljuje kot običajno.
following this, the regular application of evra is resumed.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
stanje dinamičnega ravnovesja je doseženo pri drugi aplikaciji transdermalnega obliža.
steady-state conditions are reached during the second application of the transdermal patch.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
preob utljivost na u inkovino ali druge pomožne snovi transdermalnega obliža.
hypersensitivity to the active substance or to any other excipients of the transdermal patch.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
mesto uporabe naj bo pokrito še nadaljnjih 10 dni po odstranitvi transdermalnega obliža.
continue to keep the application site covered for a further 10 days after removing the transdermal patch.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
lepljiva stran transdermalnega obliža je pokrita s čvrsto plastično podlogo iz dveh delov.
the sticky side of the transdermal patch is covered by a two-piece rigid plastic film.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
transdermalnega obliža ne smemo namestiti na kožo, ki je rdeča, vneta ali poškodovana.
the transdermal patch should not be placed on skin that is red, irritated or damaged.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
koncentracija oksibutinina v plazmi pade v 1 do 2 urah po odstranitvi transdermalnega sistema / sistemov.
plasma concentration of oxybutynin declines within 1 to 2 hours after removal of transdermal system(s).
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
iz 1 transdermalnega obliža se sprostijo 203 mikrogrami norelgestromina in 33,9 mikrogramov etinilestradiola v 24 urah.
1 patch releases: 203 micrograms norelgestromin and 33.9 micrograms ethinyl estradiol per 24 hours
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
na voljo je v obliki transdermalnega obliža (obliža, ki dovaja zdravilo prek kože).
it is available as a transdermal patch (a patch that delivers a medicine across the skin).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
po namestitvi transdermalnega obliža sancuso se granisetron absorbira počasi, največje koncentracije se dosežejo med 24 in 48 urami.
following sancuso application, granisetron is absorbed slowly, with maximal concentrations reached between 24 and 48 hours.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
da bi kar najbolj zmanjšali možnost draženja kože, se transdermalnega obliža ne sme ponovno namestiti na isti predel kože v roku 14 dni.
reapplication to the exact same skin location within 14 days should be avoided to minimise the potential risk of skin irritation.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
prehod z drugega kombiniranega hormonskega kontraceptiva (kombiniranih kontracepcijskih tabletk, vaginalnega obročka ali transdermalnega obliža)
when changing from another combined hormonal contraceptive (combined pill, vaginal ring, or transdermal patch)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
na stegno ali na trebuh transdermalnega obliža ni priporočljivo nameščati, ker so opazili zmanjšano biološko uporabnost rivastigmina v primerih namestitve na te predele.
it is not recommended to apply the transdermal patch to the thigh or to the abdomen due to decreased bioavailability of rivastigmine observed when the transdermal patch is applied to these areas of the body.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
vendar pa se ti dogodki niso pojavljali pogosteje pri uporabi transdermalnega obliža z rivastigminom 13,3 mg/24 h v primerjavi s placebom.
however, these events did not occur at a higher frequency with rivastigmine 13.3 mg/24 h transdermal patches than with placebo.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
bolnike in njihove negovalce je treba opozoriti na pomembne napotke za uporabo transdermalnega obliža exelon (glejte poglavje 4.2).
patients and their caregivers must be instructed on important administration instructions for exelon transdermal patch (see section 4.2).
Last Update: 2017-04-26
Usage Frequency: 1
Quality: